Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News BioNTech SE BNTX

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:BNTX)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)

GlobeNewswire 5 days ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

GlobeNewswire 6 days ago

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types

GlobeNewswire June 2, 2025

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

GlobeNewswire May 27, 2025

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

GlobeNewswire May 5, 2025

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

GlobeNewswire May 5, 2025

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

GlobeNewswire April 24, 2025

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

GlobeNewswire April 22, 2025

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

GlobeNewswire March 10, 2025

Bullboard Posts (NDAQ:BNTX)

Catastrophic Contagion 2025 - Mark the Date, and Be Ready!

if its what Bill Gates is into., podcast..  
petrojell - December 14, 2022

BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion

While many may view the pandemic as being over, the financial results of BioNTech  continue to say otherwise. The company...
AwareInvestor - May 9, 2022

BNTX to 500$? MUST video before it too late!

We don't make guesses but fact-based analysis. Check out and decide for yourself. Thank you:) https://www.youtube.com/watch?v...
latenightstocks - May 19, 2021

Biotech Top 5

What are your Top 5 Biotechs? 1. BioNTech 2. Bionano 3. Jaguar Health 4. Ocugen 5...perhaps the best one... WPD Pharmaceuticals (!?!)
Blocky - January 17, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Can the President Overrule the FDA on Vaccines?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020